Greenhawt M, Shaker M, Winders T, et al. - To create as well as evaluate the acceptability of a decision-aid for commercial peanut allergy therapies, researchers performed this study wherein they developed this decision-aid in three stages. They undertook a qualitative study to evaluate decisional requirements. Then, a draft decision-aid was created via multiple iterations in accordance with international guidelines and decision-aid experts. The final stage was to evaluate decisional acceptability, decisional conflict, and decisional self-efficacy associated with applying the decision-aid. Finally, a 4-page aid with 7 parts was developed, describing the therapies, the important risks and advantages of the therapy options, the relative significance of key attributes of the therapies, and a self-check evaluation concerning informational adequacy and how to take the next steps. This decision-aid was introduced as an instrument to assist caregivers to navigate the complexity of decision-making for peanut allergy treatment choices. Findings revealed good acceptability of this decision aid, and scores indicated that its use can enhance decisional self-efficacy and reduce decisional conflict.